Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Reinforces supportive care as mainstay in shock-related organ failure; leaves open targeted therapies for future trials.
The most prominent contributions to multiple organ failure, multiple organ dysfunction syndrome, and systemic inflammatory response syndrome are described in this article. However, it is quite possible that there are others that have been missed. The problem of organ failure continues to perplex clinicians and scientists, and it contributes to fatal outcomes for patients with illnesses, infections, and injuries after operations. Although we know a fair bit about these problems, we frequently can do little about it. The best approach remains support to prevent failure.
No takes yet. Share an insight, caveat, or question.
Arthur E. Baue (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: